Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for ITP in Pregnancy
NCT02751593Phase 3Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, open-label, single-arm trial of dexamethasone in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Primary endpoint: Response rate (CR+R) at 3 months. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02751593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02751593.